Reckitt now expects 3.5%–4.5% full-year Core like-for-like sales growth. Its Q3 Core growth of 3.3% contrasts with a 6.9% fall in reported Group revenue, partly reflecting the disposal of Essential Home.
Supply limits shape the outlook
Reckitt revised its full-year Core like-for-like net revenue growth outlook to 3.5%–4.5% in its 27 October trading update. The company linked the change to temporary manufacturing constraints affecting Lysol, slower growth in China’s vitamins, minerals and supplements category, and early fourth-quarter demand for seasonal cold-and-flu products. These are management’s explanations and expectations, not independently established market drivers.
Core Reckitt’s third-quarter like-for-like net revenue increased 3.3%, or 3.9% excluding Russia Hygiene. In contrast, Group net revenue reported under International Financial Reporting Standards, or IFRS, declined 6.9%. The company said the reported decline primarily reflected the prior-year contribution from Essential Home. The percentages therefore cover different scopes and bases; the Core comparable-growth measure should not be labelled reported Group growth.
Demand and the ability to supply are separate
North America’s Core like-for-like net revenue fell 1.3% in the quarter. Reckitt said manufacturing capacity constraints prevented it from fully meeting Lysol demand while it upgraded capabilities. It also cited the timing of retailer orders and expects some reversal in the fourth quarter. That expected recovery remains a forecast, rather than revenue already reported.
Emerging Markets recorded 8.0% Core like-for-like growth, while Europe returned to growth at 0.8%. Those regional measures do not change the Group IFRS comparison. For readers evaluating the update, it is useful to track both the continuing portfolio’s comparable performance and the revenue recorded across the reporting group.
What remains to be delivered
Reckitt retained its 24.9%–25.6% full-year adjusted operating-profit margin expectation for Core Reckitt plus Mead Johnson Nutrition. This is an adjusted forecast, not a reported quarterly margin or guaranteed outcome. Later disclosures will show whether supply improvements, consumer demand and order timing support delivery. No stock-price reaction, analyst-consensus comparison or investment-return claim has been verified for this report.
| Measure | Disclosed figure | Basis or caveat | Primary evidence |
|---|---|---|---|
| Q3 Core net revenue growth | +3.3% like for like | Company comparable measure; +3.9% excluding Russia Hygiene | Reckitt Q3 release |
| Q3 Group net revenue | −6.9% under IFRS | Reported Group scope; Essential Home prior-year contribution matters | Reckitt Q3 release |
| 2026 Core growth outlook | +3.5% to +4.5% like for like | Management forecast, not achieved sales | Reckitt Q3 release |
| 2026 adjusted margin outlook | 24.9%–25.6% | Core Reckitt plus Mead Johnson Nutrition; forecast | Reckitt Q3 release |
Primary evidence: Reckitt Benckiser Group plc Q3 release dated 27 October 2026, observed at 2026-10-27T10:57:12.760Z. Exact official-page HTML is retained locally. Figures use the currencies and reporting bases stated above.
The 29 September pre-close aide-memoire repeated the earlier 4%–5% Core growth outlook. It is historical evidence of the previous forecast, not a second announcement of Q3 results. Supplementary document observed and reviewed at 2026-10-27T10:59:04.748Z.
AI-assisted reporting checked against the linked official source; not independent human editorial approval. Publisher-designated author: Tatai. Information only, not investment advice.
Recorded source observation: . This is a source-check timestamp, not a market quote or a new article update.